CNBC's Jim Cramer talks about small-cap biotech company Kura Oncology and analyzes the company's stock performance. Read more
Cnbc - Dec 20
Sutro Biopharma, Inc. (NASDAQ:STRO – Free Report) – Investment analysts at Wedbush upped their FY2028 EPS estimates for Sutro Biopharma in a research note issued to investors on Wednesday, November 12th. Wedbush analyst D. Nierengarten now expects that the company will post earnings per share of ... Read more
Americanbankingnews - Nov 19
Insider & Institutional Ownership 39.4% of shares of all “Pharmaceutical preparations” companies are held by institutional investors. 5.5% of Statera Biopharma shares are held by company insiders. Comparatively, 13.8% of shares of all “Pharmaceutical preparations” companies are held by company in... Read more
Watch List News - Nov 17
Valuation and Earnings This table compares Statera Biopharma and its rivals gross revenue, earnings per share (EPS) and valuation. Gross Revenue Net Income Price/Earnings Ratio Statera Biopharma N/A N/A 0.00 Statera Biopharma Competitors $439.17 million -$68.88 million -10.05 Statera Biopharma’s ... Read more
Ticker Report - Nov 17
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report)’s stock price gapped down before the market opened on Thursday . The stock had previously closed at $10.34, but opened at $9.00. Day One Biopharmaceuticals shares last traded at $9.9350, with a volume of 902,966 shares. Wall Street ... Read more
Markets Daily - Nov 15
NEWARK, Del. and ATLANTA, Nov. 12, 2025 /PRNewswire/ -- The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) and the Open Applications Group, Inc. (OAGi) are proud to announce the release of a groundbreaking set of ontologies designed to enhance... Read more
Eagletribune - Nov 12
Several top biotech executives are slated to speak at a "Make America Healthy Again" event on Wednesday that's headlined by federal health officials, according to an agenda reviewed by Endpoints News. On a panel entitled ... Read more
Endpoints News - Nov 11
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Nucleic Acid Therapeutics Market - (By Technology (RNA targeted therapeutics, Gene Therapies, Epigenetic and microRNA modulating therapies, Genome editing therapies, Others), By Application (Autoimmun... Read more
Openpr.com - Nov 04
Sometimes the biggest moments at a conference happen backstage. At the annual STAT Summit, that kind of moment involved a pharma CEO and a toddler in a tuxedo. Read more
Stat - Oct 24
According to Towards Chemical and Materials, the global biopharma plastic market size is calculated at USD 6.68 billion in 2025 and is expected to be worth around USD 13.35 billion by 2034, growing at a compound annual growth rate (CAGR) of 7.99% over the forecast period 2025 to 2034. According t... Read more
Globenewswire_fr - Oct 09
